Evidence map›Paper›PMID 34765272›Full record

ArticleJournal of pharmaceutical analysis2021

Engineered polymer nanoparticles incorporating l-amino acid groups as affinity reagents for fibrinogen.

Yongyan Zhu, Ruixuan Liu, Dengyu Wu, Qianqian Yu, Kenneth J Shea, Quanhong Zhu

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 11 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Yongyan ZhuSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
Ruixuan LiuSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
Dengyu WuSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
Qianqian YuSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
Kenneth J SheaDepartment of Chemistry, University of California, Irvine, CA, 92697, USA.
Quanhong ZhuSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China.
Southern Medical University · CNKey Laboratory of Guangdong Province · CNUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic polymer hydrogel nanoparticles (NPs) were developed to function as abiotic affinity reagents for fibrinogen. These NPs were made using both temperature-sensitive N-isopropyl acrylamide (NIPAm) and l-amino acid monomers. Five kinds of l-amino acids were acryloylated to obtain functional monomers: l-phenylalanine (Phe) and l-leucine (Leu) with hydrophobic side chains, l-glutamic acid (Glu) with negative charges, and l-lysine (Lys) and l-arginine (Arg) with positive charges. After incubating the NPs with fibrinogen, γ-globulin, and human serum albumin (HSA) respectively, the NPs that incorporated N-acryloyl-Arg monomers (AArg@NPs) showed the strongest and most specific binding affinity to fibrinogen, when compared with γ-globulin and HSA. Additionally, the fibrinogen-AArg binding model had the best docking scores, and this may be due to the interaction of positively charged AArg@NPs and the negatively charged fibrinogen D domain and the hydrophobic interaction between them. The specific adsorption of AArg@NPs to fibrinogen was also confirmed by the immunoprecipitation assay, as the AArg@NPs selectively trapped the fibrinogen from a human plasma protein mixture. AArg@NPs had a strong selectivity for, and specificity to, fibrinogen and may be developed as a potential human fibrinogen-specific affinity reagent.

Indexed as

Affinity reagentAmino-acid monomersArginineFibrinogenProtein interactionSynthetic polymer nanoparticles

Identifiers

PMID34765272
PMCPMC8572708
OpenAlexW3093793016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.